Metabolic research studies how organisms regulate energy — glucose handling, adiposity, and energy expenditure — at the level of receptors and signalling pathways. The research compounds in this category appear throughout that literature: dual GLP-1/GIP receptor agonism (tirzepatide), GLP-1/GIP/glucagon triple agonism (retatrutide), amylin analogues (cagrilintide), the C-terminal growth-hormone fragment AOD-9604, and the pan-ERR agonist SLU-PP-332. Published studies in this domain report receptor-signalling, body-composition, and glucose-regulation endpoints measured in defined preclinical and clinical-pharmacology models. Every compound here is supplied strictly for in-vitro and in-vivo laboratory research. Each product page carries its full reference list — read what the field actually reports.
